Dr. J. Lalezari Presentation to NIH colleaques: Le
Post# of 148109
"I don't know that there's another therapeutic in this population that's given a signal of 82% reduced mortality. I mean that's more than I expected, that's for sure.
But if there was ever a situation and if there was ever a drug, if there was ever a company that needed the help of our Federal government, it's this one."
Scott Kelly was definitely the wrong COB turned CMO.